Alejandro Quilez Martinez

Vicente-Pascual, M; Quilez, A; Gil, MP; Gonzalez-Mingot, C; Vazquez-Justes, D; Mauri-Capdevila, G; Sanahuja, J; Garcia-Vazquez, C; Purroy, F

The influence of organisational management on door-to-needle times for fibrinolytic treatment

NEUROLOGIA 38 313-318. 01/06/2023.

[doi:10.1016/j.nrl.2020.10.014]

Vicente-Pascual M; Quilez A; Gil MP; González-Mingot C; Vázquez-Justes D; Mauri-Capdevila G; Sanahuja J; García-Vázquez C; Purroy F

The influence of organisational management on door-to-needle times for fibrinolytic treatment.

Neurologia (barcelona, Spain) 38 313-318. 01/06/2023.

[doi:10.1016/j.nrleng.2020.10.010]

Purroy F; Vicente-Pascual M; Arque G; Baraldes-Rovira M; Begue R; Gallego Y; Gil MI; Gil-Villar MP; Mauri G; Quilez A; Sanahuja J; Vazquez-Justes D

Sex-Related Differences in Clinical Features, Neuroimaging, and Long-Term Prognosis After Transient Ischemic Attack.

STROKE 52 424-433. 25/01/2021.

[doi:10.1161/STROKEAHA.120.032814]

Quilez, A; Baraldes-Rovira, M; Gallego, Y; Sanahuja, J; Mauri-Capdevila, G; Purroy, F

Risk-benefit assessment of treatment of epileptic women of childbearing age with valproic acid.

SEIZURE-EUROPEAN JOURNAL OF EPILEPSY 82 27-30. 01/11/2020.

[doi:10.1016/j.seizure.2020.09.008]

Santamarina, E; Gonzalez-Cuevas, M; Toledo, M; Jimenez, M; Becerra, JL; Quilez, A; Suller, A; Mauri, JA; Fernandez, A; Marinas, A; Quintana, M; Puig, XS

Intravenous lacosamide (LCM) in status epilepticus (SE): Weight-adjusted dose and efficacy

EPILEPSY & BEHAVIOR 84 93-98. 01/07/2018.

[doi:10.1016/j.yebeh.2018.04.025]

Vena, AB; Cambray, S; Molina-Seguin, J; Colàs-Campàs L; Sanahuja, J; Quilez, A; Gonzalez-Mingot, C; Gil-Villar, MP; Benabdelhak, I; Mauri-Capdevila, G; Purroy, F

Clinical Evolution of Elderly Adults with Ischemic Stroke

JOURNAL OF THE AMERICAN GERIATRICS SOCIETY 64 2167-2170. 01/10/2016.

[doi:10.1111/jgs.14426]

Oriolo G; Quílez A; Pintor L

Diaphragmatic flutter as conversion symptom: a case report of a neurology-psychiatry-interface disorder.

ACTAS ESPANOLAS DE PSIQUIATRIA 44 193-202. 01/09/2016.

Purroy F; Suárez-Luis I; Cambray S; Farré J; Benabdelhak I; Mauri-Capdevila G; Sanahuja J; Quílez A; Begué R; Gil MI; Molina-Seguin J; Torreguitart N

The determination of copeptin levels helps management decisions among transient ischaemic attack patients

ACTA NEUROLOGICA SCANDINAVICA 134 140-147. 01/08/2016.

[doi:10.1111/ane.12523]

Vilanova MB; Mauri-Capdevila G; Sanahuja J; Quilez A; Piñol-Ripoll G; Begué R; Gil MI; Codina-Barios MC; Benabdelhak I; Purroy F

Prediction of myocardial infarction in patients with transient ischaemic attack

ACTA NEUROLOGICA SCANDINAVICA 131 111-119. 01/02/2015.

[doi:10.1111/ane.12291]

Jové M; Mauri-Capdevila G; Suárez I; Cambray S; Sanahuja J; Quílez A; Farré J; Benabdelhak I; Pamplona R; Portero-Otín M; Purroy F

Metabolomics predicts stroke recurrence after transient ischemic attack

Neurology 84 36-45. 06/01/2015.

[doi:10.1212/WNL.0000000000001093]

Purroy F; Suárez-Luis I; Mauri-Capdevila G; Cambray S; Farré J; Sanahuja J; Piñol-Ripoll G; Quílez A; González-Mingot C; Begué R; Gil MI; Fernández E; Benabdelhak I

N- terminal pro- brain natriuretic peptide level determined at different times identifies transient ischaemic attack patients with atrial fibrillation

EUROPEAN JOURNAL OF NEUROLOGY 21 679-683. 01/04/2014.

[doi:10.1111/ene.12222]

Purroy, Francisco; Begue, Robert; Quilez, Alejandro; Sanahuja, Jordi; Isabel Gil, Maria

Contribution of High-b-Value Diffusion-Weighted Imaging in Determination of Brain Ischemia in Transient Ischemic Attack Patients

JOURNAL OF NEUROIMAGING 23 33-38. 01/01/2013.

[doi:10.1111/j.1552-6569.2011.00696.x]